Activists write to PM Modi on unethical practices at Covaxin s Bhopal trial site
Premium
Bhopal: A medic administers Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), during the Phase- 3 trials at Peoples College of Medical Sciences & Research Centre in Bhopal.
(PTI)
Bharat Biotech, in its statement, said that the Covaxin Phase 3 study is being conducted across 26 sites in India in compliance with the study protocol, Indian good clinical practice guidelines, and all regulatory provisions that apply to clinical trials in the country
Share Via
Read Full Story
Activists involved with the Bhopal gas tragedy have written to Prime Minister Narendra Modi and health minister Harsh Vardhan about the unethical practices at the clinical trial site for Bharat Biotech s Covaxin at the city’s Peoples College of Medical Sciences & Research Centre.
Asia Today: Thailand counts more virus cases, limits travel yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
URL copied
Opinion | Let us keep politics away from Covid vaccine issue
Even before the first Covid vaccine is yet to be given in India, political parties have already started politicizing the issue by questioning emergency approval given to the indigenous Covaxin vaccine developed by a Hyderabad company Bharat Biotech. On Sunday, the Drugs Controller General of India formally announced the emergency approval for ârestricted useâ of Bharat Biotechâs Covaxin and the Covishield vaccine, developed by Oxford-AstraZeneca and Serum Institute of India.
The Controller General V G Somani said both the drug firms have submitted data on their trial runs and both have been granted permission. He said the overall efficacy of Covishield was 70.42 per cent, while Covaxin âis safe and it provides a robust immune responseâ. âWe will never approve anything if there is slightest of safety concernâ, he added. Rumours being spread that the vaccine could cau